日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Synergistic Treatment of Prostate Cancer and Multiple Myeloma using CD46-Targeted Radioimmunotherapy Antibody-Drug Conjugates

利用CD46靶向放射免疫疗法抗体-药物偶联物协同治疗前列腺癌和多发性骨髓瘤

Bidkar, Anil P; Bidlingmaier, Scott; Wadhwa, Anju; Mayne, Ellis; Raveendran, Athira; Naik, Shubhankar; Xue, Cheng; Basak, Megha; Bobba, Kondapa Naidu; Patiño-Escobar, Bonell; Greenland, Nancy; Camara Serrano, Juan Antonio; Steri, Veronica; Chou, Jonathan; Wiita, Arun; He, Jiang; Wilson, David M; Aggarwal, Rahul; VanBrocklin, Henry F; Seo, Youngho; Liu, Bin; Flavell, Robert R

Unraveling the Enigma of Melanoma Brain Metastasis: New Molecular Insights and Therapeutic Directions

揭开黑色素瘤脑转移之谜:新的分子见解和治疗方向

O'Toole, Kayla T; Roan, Brandon M; Hardman, Timothy M; Phillips, Peyton P; VanBrocklin, Evan M; Parkman, Gennie L; Holmen, Sheri L

Systemic hypoxia suppresses solid tumor growth

全身性缺氧抑制实体瘤生长

Midha, Ayush D; Chew, Brandon T L; Choi, Benedict M H; Suh, Jung Min; Carpenter, Chris; Baik, Alan H; Joshi, Tej A; Blume, Skyler Y; Haribowo, Augustinus G; Ruivo, Pedro; Flanigan, Will R; Garg, Ankur; Zhang, Daniel D; Subramanyam, Vishvak; Shuere, Rebecca; Seo, Youngho; VanBrocklin, Henry; Goodarzi, Hani; Jain, Isha H

Transdermal delivery of ultradeformable cationic liposomes complexed with miR211-5p (UCL-211) stabilizes BRAFV600E+ melanocytic nevi.

经皮递送与 miR211-5p (UCL-211) 复合的超可变形阳离子脂质体可稳定 BRAFV600E+ 黑素细胞痣

Chhibber Tanya, Scherzer Michael T, Prokofyeva Anastasia, Becker Carly, Zitnay Rebecca Goldstein, Smith Eric, Khurana Nitish, Skliar Mikhail, Deacon Dekker C, VanBrocklin Matthew W, Ghandehari Hamidreza, Judson-Torres Robert L, Jafari Paris

Effective Treatment of Disseminated Prostate Cancer Using CD46-Targeted 225Ac Therapy.

采用 CD46 靶向 225Ac 疗法有效治疗转移性前列腺癌

Bidkar Anil P, Peter Robin, Wadhwa Anju, Bobba Kondapa Naidu, Bidlingmaier Scott, Meher Niranjan, Chou Jonathan, Greenland Nancy, Dasari Chandrashekhar, Naik Shubhankar, Raveendran Athira, Basak Megha, Camara Serrano Juan Antonio, Steri Veronica, Kogan Scott, Oskowitz Adam, He Jiang, Wilson David M, Aggarwal Rahul, Sriram Renuka, VanBrocklin Henry F, Seo Youngho, Liu Bin, Flavell Robert R

A BRN2:MYC transcriptional axis regulates interconversion between therapy-resistant and tumorigenic phenotypes in melanoma

BRN2:MYC转录轴调控黑色素瘤中治疗耐药表型和致瘤表型之间的相互转化

Zhang, Yuntian; Urquijo, Marcus A; Zitnay, Rebecca G; Marks, Kayla; Belote, Rachel L; Hansen, Maike M K; Ferita, Montana; Neuendorf, Hannah M; Liu, Tong; Smith, Eric A; Mehrabad, Elnaz Mirzaei; Hejna, Miroslav; Moustafa, Tarek E; Lange, Devin; Hu, Min; Vand-Rajabpour, Fatemeh; Done, Anne; Becker, Carly A; Lieberman, Matthew; Chang, Matthew; Lohman, Brian K; Stubben, Chris J; Reeves, Melissa Q; Zhang, Xiaoyang; Weinberger, Leor S; VanBrocklin, Matthew W; Deacon, Dekker C; Grossman, Douglas; Spike, Benjamin T; Lex, Alexander; Boyle, Glen M; Kulkarni, Rajan; Zangle, Thomas A; Judson-Torres, Robert L

PET Imaging Using 89Zr-Labeled StarPEG Nanocarriers Reveals Heterogeneous Enhanced Permeability and Retention in Prostate Cancer

利用 89Zr 标记的 StarPEG 纳米载体进行 PET 成像揭示了前列腺癌中异质性增强的渗透性和滞留性

Niranjan Meher,Anil P Bidkar,Anju Wadhwa,Kondapa Naidu Bobba,Suchi Dhrona,Chandrashekhar Dasari,Changhua Mu,Cyril O Y Fong,Juan A Cámara,Umama Ali,Megha Basak,David Bulkley,Veronica Steri,Shaun D Fontaine,Jun Zhu,Adam Oskowitz,Rahul R Aggarwal,Renuka Sriram,Jonathan Chou,David M Wilson,Youngho Seo,Daniel V Santi,Gary W Ashley,Henry F VanBrocklin,Robert R Flavell

Evaluation of (134)Ce/(134)La-PSMA-617 for PET Imaging and Auger Electron Therapy of Prostate Cancer

评估 (134)Ce/(134)La-PSMA-617 在前列腺癌 PET 成像和俄歇电子治疗中的应用

Bobba, Kondapa Naidu; Wadhwa, Anju; Bidkar, Anil P; Raveendran, Athira; Garcia, Luis; Greenland, Nancy; Wilson, David M; Seo, Youngho; VanBrocklin, Henry F; Flavell, Robert R

Actinium-225 targeted alpha particle therapy for prostate cancer

锕-225靶向α粒子疗法治疗前列腺癌

Bidkar, Anil P; Zerefa, Luann; Yadav, Surekha; VanBrocklin, Henry F; Flavell, Robert R

Development of CD46 targeted alpha theranostics in prostate cancer using 134Ce/225Ac-Macropa-PEG4-YS5

使用 134Ce/225Ac-Macropa-PEG4-YS5 开发针对前列腺癌的 CD46 靶向 α 治疗诊断剂

Kondapa Naidu Bobba, Anil P Bidkar, Anju Wadhwa, Niranjan Meher, Suchi Drona, Alexandre M Sorlin, Scott Bidlingmaier, Li Zhang, David M Wilson, Emily Chan, Nancy Y Greenland, Rahul Aggarwal, Henry F VanBrocklin, Jiang He, Jonathan Chou, Youngho Seo, Bin Liu, Robert R Flavell